Stay updated on VenDex vs PomDex in t(11;14)+ MM Clinical Trial

Sign up to get notified when there's something new on the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added related topics 'Multiple myeloma' and 'MedlinePlus Genetics' and updated the page revision from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-09T01:56:36.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    CANOVA primary results publication added: Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-positive relapsed or refractory MM published in J Clin Oncol (2026; 44(3):164-175; DOI: 10.1200/JCO-25-00924; Epub 2025-12-10). The earlier ahead-of-print citation was replaced with the updated JCO citation.
    Difference
    0.0%
    Check dated 2026-02-15T12:34:47.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A small update to the site's revision history was made, adding Revision: v3.4.1 and removing Revision: v3.4.0, reflecting internal version control rather than changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-08T04:53:55.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Removed 'Multiple Myeloma' and 'MedlinePlus Genetics' from the study page's related topics/keywords. This change removes metadata without altering core trial content or patient information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-01T01:32:59.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The additions introduce a glossary display and related topics, such as Multiple Myeloma and MedlinePlus Genetics, and include visibility of QC-related metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). These changes are minor UI/metadata updates that do not affect core trial content, eligibility, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-24T22:22:09.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4 added, and related topics such as Multiple myeloma and MedlinePlus Genetics, plus the prior revision tag v3.3.3, were removed. The main study details and content remain unchanged.
    Difference
    0.1%
    Check dated 2026-01-18T01:29:22.000Z thumbnail image

Stay in the know with updates to VenDex vs PomDex in t(11;14)+ MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page.